Neumora Therapeutics, Inc. (NMRA) Tops Q3 EPS by 20c
Get Alerts NMRA Hot Sheet
Join SI Premium – FREE
Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q3 EPS of ($0.45), $0.20 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aggreko files for proposed IPO
- Philips prices €650M EU green bond due 2034
- Broadcom credit risk measures rise amid AI financing deals
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share